Sensei Biotherapeutics, Inc. SNSE 深 沪
等待开盘 03-27 09:30:00 美东时间
26.88
-2.610
-8.85%
华盛通- 最 高35.00
- 今 开28.97
- 成交量 7.60万股
- 最 低 26.09
- 昨 收 29.49
- 总市值 82.33万
- 52周最高 36.76
- 市盈率 静 --
- 换手率 248.22%
- 52周最低 0.2605
- 委 比 9.25%
- 总股本 3.06万
- 历史最高 36.76
- 量 比 0
- 振 幅 30.21%
- 历史最低 0.25
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sensei Biotherapeutics Stock Soars 230% After Faeth Deal
SNSE up on acquisition of Faeth Therapeutics, $200M private placement, and addition of PIKTOR to pipeline targeting cancer.
02-19 01:09
Dow Gains 100 Points; Analog Devices Posts Upbeat Q1 Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining around...
02-18 22:48
Sensei Biotherapeutics Acquires Faeth Therapeutics In Stock-To-Stock Transaction
The acquisition of Faeth was structured as a stock-for-stock transaction pursuant to which all of Faeth's outstanding equity interests were exchanged based on a fixed exchange ratio for a combination of 252,210 shares of
02-18 21:11
Sensei Biotherapeutics To Present Preclinical Data On SNS-103 At The CRI-ENCI Eighth International Immunotherapy Conference September 8-11, 2024
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that preclinical data on SNS-103 will be presented in a poster session at the CRI-ENCI Eighth Internation...
2024-09-05 04:19
